ArticleBreast cancer (Tokyo, Japan)2026
Patterns of ipsilateral breast tumor recurrence following partial vs. whole-breast irradiation: a retrospective comparative study of breast-conserving therapy.
Article in Breast cancer (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposePartial-breast irradiation (PBI) is an alternative to whole-breast irradiation (WBI) in breast-conserving therapy. This study evaluated the incidence and temporal patterns of ipsilateral breast tumor recurrence (IBTR), classified as true recurrence (TR) or new primary tumor (NP), and compared the impact of PBI and WBI. METHODS AND MATERIALS: We retrospectively analyzed 1,395 patients treated with PBI or WBI between 2008 and 2024. PBI was delivered perioperatively using multicatheter interstitial brachytherapy (32 Gy in 8 fractions or 25.2 Gy in 4 fractions) or WBI (50 Gy in 25 fractions). The incidence, timing, and predictors of TR and NP were evaluated.
resultsAt a median follow-up of 6.7 years, 40 IBTRs (2.9%) occurred: 20 TRs (1.4%) and 20 NPs (1.4%). Five- and 10-year breast cancer-specific survival rates were 85.4% and 60.1% for TR, and 100% and 100% for NP (p < 0.01). TR rates were similar between the PBI and WBI cohorts (1.4% vs. 1.6%, p = 0.68), but NP occurred more frequently after PBI (1.9% vs. 0.5%, p = 0.04). Multivariate analysis revealed that younger age (< 50 years) was independently associated with TR (HR, 2.51; p = 0.01), and PBI was significantly associated with NP (HR, 4.44; p < 0.01).
conclusionsPBI provides local control comparable to WBI for TR; however, it may be associated with an increased risk of NP, which represents a potential drawback of PBI.
Indexed as
Identifiers
41258584What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.